au.\*:("PASSALACQUA, G")
Results 1 to 25 of 87
Selection :
Il bilancio dello Stato, un istituto trasformato. (La comptabilité publique, une institution transformée)PASSALACQUA, G.Rivista Trimestrale di Scienza della Amministrazione Milano. 1978, Vol 25, Num 3, pp 512-542Article
Treating the allergic patient: think globally, treat globallyPASSALACQUA, G; CANONICA, G. W.Allergy (Copenhagen). 2002, Vol 57, Num 10, pp 876-883, issn 0105-4538Article
Alternative routes for allergen-specific immunotherapyPASSALACQUA, G; CANONICA, G. W.Journal of investigational allergology & clinical immunology. 1996, Vol 6, Num 2, pp 81-87, issn 1018-9068Article
Survey on the safety of a no-updosing regimen of sublingual immunotherapyMUSARRA, A; CILIA, M; PECORA, S et al.European annals of allergy and clinical immunology. 2006, Vol 38, Num 9, pp 313-314, issn 1764-1489, 2 p.Article
Dermatological powder as hidden cause of occupational allergy due to casein: a case reportBONADONNA, P; SENNA, G; PASSALACQUA, G et al.Occupational and environmental medicine (London). 2003, Vol 60, Num 8, pp 609-610, issn 1351-0711, 2 p.Article
Sublingual immunotherapy in the treatment of adult allergic rhinitis patientsCANONICA, G. W; PASSALACQUA, G.Allergy. Supplement. 2006, Vol 61, Num 81, pp 20-23, issn 0108-1675, 4 p.Article
Sublingual IT in OASLOMBARDI, C; CANONICA, G. W; PASSALACQUA, G et al.Allergy (Copenhagen). 2000, Vol 55, Num 7, pp 677-678, issn 0105-4538Article
The perception of allergen-specific immunotherapy among chest physicians: an Italian surveyLOMBARDI, C; CANONICA, G. W; PASSALACQUA, G et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 4, pp 132-136, issn 1764-1489, 5 p.Article
An adult case of eosinophilic pyloric stenosis maintained on remission with oral budesonideLOMBARDI, C; SALAMI, A; PASSALACQUA, G et al.European annals of allergy and clinical immunology. 2011, Vol 43, Num 1, pp 29-30, issn 1764-1489, 2 p.Article
Long-lasting effect of a monophosphoryl lipid-adjuvanted immunotherapy to parietaria. A controlled field studyMUSARRA, A; BIGNARDI, D; TROISE, C et al.European annals of allergy and clinical immunology. 2010, Vol 42, Num 3, pp 115-119, issn 1764-1489, 5 p.Article
Position paper: controversial and unproven diagnostic procedures for food allergySENNA, G; PASSALACQUA, G; LOMBARDI, C et al.European annals of allergy and clinical immunology. 2004, Vol 36, Num 4, pp 139-145, issn 1764-1489, 7 p.Article
Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approachCORTELLINI, G; TESTI, S; CANONICA, Gw et al.European annals of allergy and clinical immunology. 2012, Vol 44, Num 4, pp 160-162, issn 1764-1489, 3 p.Article
Important research questions in allergy and related diseases : nonallergic rhinitis: a GA2LEN paperBOUSQUET, J; FOKKENS, W; BONINI, S et al.Allergy (Copenhagen). 2008, Vol 63, Num 7, pp 842-853, issn 0105-4538, 12 p.Article
Effect of statins on fibroblasts from human nasal polyps and turbinatesFOLLI, C; DESCALZI, D; BERTOLINI, S et al.European annals of allergy and clinical immunology. 2008, Vol 40, Num 3, pp 84-89, issn 1764-1489, 6 p.Article
Asthma treatment : 'magic bullets which seek their own targets' : AsthmaTARANTINI, F; BAIARDINI, I; PASSALACQUA, G et al.Allergy (Copenhagen). 2007, Vol 62, Num 6, pp 605-610, issn 0105-4538, 6 p.Article
Rhinitis and asthma in athletes : an ARIA document in collaboration with GA2LENBONINI, S; BONINI, M; HAAHTELA, T et al.Allergy (Copenhagen). 2006, Vol 61, Num 6, pp 681-692, issn 0105-4538, 12 p.Article
Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjectsPASSALACQUA, G; ALTRINETTI, V; MARIANI, G et al.Clinical and experimental allergy (Print). 2005, Vol 35, Num 7, pp 880-883, issn 0954-7894, 4 p.Article
Measurement of nasal IgE in an epidemiological study: Assessment of its diagnostic value in respiratory allergyMARCUCCI, F; PASSALACQUA, G; CANONICA, G.-W et al.European annals of allergy and clinical immunology. 2004, Vol 36, Num 6, pp 225-231, issn 1764-1489, 7 p.Article
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjectsSEMIZZI, M; SENNA, G; CRIVELLARO, M et al.Clinical and experimental allergy (Print). 2002, Vol 32, Num 6, pp 928-932, issn 0954-7894Article
Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteersBAGNASCO, M; PASSALACQUA, G; VILLA, G et al.Clinical and experimental allergy (Print). 2001, Vol 31, Num 1, pp 54-60, issn 0954-7894Conference Paper
Consensus statement on the treatment of allergic rhinitisVAN CAUWENBERGE, P; BACHERT, C; MYGIND, N et al.Allergy (Copenhagen). 2000, Vol 55, Num 2, pp 116-134, issn 0105-4538Article
Severe systemic reactions caused by poppy seedCRIVELLARO, M; BONADONNA, P; DAMA, A et al.Journal of investigational allergology & clinical immunology. 1999, Vol 9, Num 1, pp 58-59, issn 1018-9068Article
Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patientsDI RIENZO, V; PAGANI, A; PARMIANI, S et al.Allergy (Copenhagen). 1999, Vol 54, Num 10, pp 1110-1113, issn 0105-4538Article
Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species : A double-blind, placebo-controlled trialPASSALACQUA, G; ALBANO, M; RICCIO, A et al.Journal of allergy and clinical immunology. 1999, Vol 104, Num 5, pp 964-968, issn 0091-6749Article
Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challengeCIPRANDI, G; RICCA, V; PASSALACQUA, G et al.Clinical and experimental allergy (Print). 1998, Vol 28, Num 3, pp 293-299, issn 0954-7894Article